Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The formula YH0618 can reduce the harmful side effects of the chemotherapy drug Doxorubicin and protect healthy cells.

Scalp basal cell carcinoma may be more aggressive and harder to treat than other types, requiring special attention and further research.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Scalp cooling does not stop hair loss from radiotherapy.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

A3B5 can reduce skin pigmentation and slow melanoma growth.

Burn injuries can cause long-term itching, skin color changes, and cancer risks, needing personalized treatment.

EGFR inhibitors for lung cancer can cause severe skin issues.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

TSC2-/meth cells can cause skin lesions, hair growth, and lung issues, and may be treated with chromatin remodeling agents.

UVA1-light therapy successfully treated a child's skin condition, mycosis fungoides.

The document concludes that low-dose oral minoxidil successfully regrew hair in a patient with permanent hair loss after chemotherapy and stem cell transplant.

Allopregnanolone increases growth and changes gene activity in human brain cancer cells.

Treatment with methotrexate and prednisolone led to complete hair regrowth and no relapse for 2 years.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

DCP therapy causes side effects like weakness, flushing, headaches, and taste changes, but less frequently causes hypertension and diabetes.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Amivantamab can cause severe skin eruptions and scarring, requiring drug discontinuation and early treatment.

ONCO-NK-TRANSITION-GM1 is a low-cost, effective cancer treatment with a high cure rate and no severe side effects.

ONCO-NK-TRANSITION-GM1 is a low-cost, effective cancer treatment with a high cure rate and no severe side effects.

A 73-year-old woman with Hypopigmented Mycosis Fungoides, a rare skin lymphoma, experienced disease progression despite treatment, emphasizing the need for ongoing monitoring.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

Photodynamic therapy can potentially remove nonpigmented hair by damaging hair follicles.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Systemic mastocytosis may cause a type of hair loss called cicatricial alopecia.

Tavaborole is a safe and effective toenail fungus treatment, with the 5% solution being the best option.

Stopping heptaminol medication reversed hair color loss in a patient on dialysis.

Aqueous dispersion resin is safe to inhale at levels below 30 mg/m³.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.